Select Page

Type 1 & Retinopathy (FAME)

Have you been diagnosed with Diabetic Retinopathy? (FAME)

We are testing the effect of a cholesterol lowering drug for its effectiveness in treating retinopathy in patients with Type 1 Diabetes. This drug, known as a fenofibrate, is already approved for treatment in Type 2 Diabetes, and it is hoped this study may expand treatment to cover Type 1 Diabetes as well.

Type 1 & Retinopathy (FAME)

Have you been diagnosed with Diabetic Retinopathy? (FAME)

We are testing the effect of a cholesterol lowering drug for its effectiveness in treating retinopathy in patients with Type 1 Diabetes. This drug, known as a fenofibrate, is already approved for treatment in Type 2 Diabetes, and it is hoped this study may expand treatment to cover Type 1 Diabetes as well.

In order to complete this study (referred to as FAME), we need volunteers from the public who meet a particular criteria. You may be eligible for this study if you are:

  • aged 18 years or older
  • have Type 1 Diabetes
  • have been diagnosed with retinopathy in at least one eye
  • have NOT had laser surgery or any other eye problems

You will be medically supervised and there will be no costs involved. For more information, with no obligation, please call:

Annette – Clinical Research Coordinator (02) 4963 2323 (take option 1).
Please do leave a message with your name and contact details so we can return your call.

This study has Human Research Ethics Committee (HREC) approval.

Register Your Interest